Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management

INTRODUCTION: Chronic Myeloid Leukemia (CML) is a myeloproliferative disease that affects mainly adults between 50 and 55 years. In Brazil, information from the Sistema Único de Saúde (SUS) Outpatient Information System indicates that 12,531 patients had the Autorização de Procedimento Ambulatorial...

Descripción completa

Detalles Bibliográficos
Autores principales: Boquimpani, Carla Maria, Abdo, André Neder Ramires, Martins, Denise Pires, Lima, Luciana Britto de Abreu, Torriani, Mayde Seadi, Bendit, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910181/
https://www.ncbi.nlm.nih.gov/pubmed/32475788
http://dx.doi.org/10.1016/j.htct.2020.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910181/
https://www.ncbi.nlm.nih.gov/pubmed/32475788
http://dx.doi.org/10.1016/j.htct.2020.02.002

Ejemplares similares